Follow The Filings

MDGL position history

The shares of Madrigal Pharmaceuticals (MDGL) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q4: 153,000 shares, $44M, 0.29% of portfolio, New
  2. 2023 Q1: 163,819 shares, $40M, 0.22% of portfolio, Add +7.1%
  3. 2023 Q2: 3,319 shares, $767K, <0.01% of portfolio, Reduce −98.0%
  4. 2023 Q3: 3,319 shares, $485K, <0.01% of portfolio
  5. 2023 Q4: 3,319 shares, $768K, <0.01% of portfolio
  6. 2024 Q1: 6,638 shares, $1.8M, <0.01% of portfolio, Add +100.0%
  7. 2024 Q2: 3,319 shares, $930K, <0.01% of portfolio, Reduce −50.0%
  8. 2024 Q3: 3,319 shares, $704K, <0.01% of portfolio
  9. 2024 Q4: 3,319 shares, $1M, <0.01% of portfolio
  10. 2025 Q1: 3,319 shares, $1.1M, <0.01% of portfolio
  11. 2025 Q2: 3,319 shares, $1M, <0.01% of portfolio
  12. 2025 Q3: 6,638 shares, $3M, 0.01% of portfolio, Add +100.0%
  13. 2025 Q4: 3,319 shares, $1.9M, <0.01% of portfolio, Reduce −50.0%
  14. 2026 Q1: 3,319 shares, $1.7M, <0.01% of portfolio
  15. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders